共 50 条
- [41] Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin AmericaBLOOD, 2023, 142Pena, CamilaBove, VirginiaRiva, EloisaDuarte, PatricioSamanez-Figari, Cesar AugustoSeehaus, Cristian M.Tarin-Arzaga, LuzVon Glasenapp, Seisha AlanaBustillo, Rodrigo MenecesVasquez, Jule F.Hernandez, MarcosShanley, ClaudiaGallardo-Perez, Moises ManuelRuiz-Arguelles, Guillermo JoseMariano, RominaGilli, VirginiaGarrido, David IsraelGraffigna, PatriciaSchutz, Natalia PaolaFantl, Dorotea
- [42] Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myelomaANNALS OF HEMATOLOGY, 2011, 90 (12) : 1441 - 1447Krejci, MartaGregora, EvzenStraub, JanMinarik, JiriScudla, VlastimilAdam, ZdenekKrivanova, AndreaPour, LudekZahradova, LenkaBuchler, TomasMayer, JiriHajek, Roman
- [43] The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma PatientsCANCERS, 2020, 12 (09) : 1 - 18Robak, PawelDrozdz, IzabelaJarych, DariuszMikulski, DamianWeglowska, EdytaSiemieniuk-Rys, MonikaMisiewicz, MalgorzataStawiski, KonradFendler, WojciechSzemraj, JanuszSmolewski, PiotrRobak, Tadeusz
- [44] Patterns of Relapse or Progression After Bortezomib-Based Salvage Therapy in Patients With Relapsed/Refractory Multiple MyelomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 389 - 394Ahn, Jae-SookJung, Sung-HoonYang, Deok-HwanBae, Soo-YoungKim, Yeo-KyeoungKim, Hyeoung-JoonLee, Je-Jung
- [45] Feasibility and Activity Of Bortezomib-Based Therapy In Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With CarfilzomibBLOOD, 2013, 122 (21)Alagappan, ArtiShah, Rupin A.Thomas, Sheeba K.Weber, Donna M.Wang, MichaelAlexanian, RaymondOrlowski, Robert Z.Shah, Jatin J.
- [46] Association Of Stringed Response and Immunoparesis Normalization After Bortezomib-Based Therapy Is Related To Better Outcomes In Multiple MyelomaBLOOD, 2013, 122 (21)Andrade, Marcio M., Sr.Murillo-Florez, IldaMontes-Limon, Anelde Rueda, BeatrizGrasa, Jose-MariaGiraldo, Pilar
- [47] Radiomics Models Based on Magnetic Resonance Imaging for Prediction of the Response to Bortezomib-Based Therapy in Patients with Multiple MyelomaBIOMED RESEARCH INTERNATIONAL, 2022, 2022Li, YangYin, PingLiu, YangHao, ChuanxiChen, LeiSun, ChaoWang, SicongHong, Nan
- [48] Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myelomaAnnals of Hematology, 2011, 90 : 1441 - 1447Marta KrejciEvzen GregoraJan StraubJiri MinarikVlastimil ScudlaZdenek AdamAndrea KrivanovaLudek PourLenka ZahradovaTomas BuchlerJiri MayerRoman Hajek
- [49] Therapy response by decrease of free light chain concentration in multiple myeloma patients treated with bortezomib/doxorubicin/dexamethasone as first-line therapyBLOOD, 2007, 110 (11) : 278B - 278BZinke-Cerwenka, WilmaStojakovic, TatjanaSchamagl, HubertWassertheurer, SabineLinkesch, Werner
- [50] BORTEZOMIB IS COST-EFFECTIVE FOR FIRST-LINE TREATMENT OF MULTIPLE MYELOMA IN SWEDENVALUE IN HEALTH, 2010, 13 (03) : A40 - A40Rickert, J. B.Hornberger, J.Liwing, J.Aschan, J.Gjonnes, L.Dhawan, R.